Personal Data of Study Subjects Sample Clauses

Personal Data of Study Subjects. Sponsor shall be an independent Controller with respect to its Processing of Personal Data contained in the Study data that is reported by Institution to Sponsor or Covance. Institution shall continue to be an independent Controller of Personal Data Processed by Institution with respect to the treatment of the Study subject pursuant to medical standard of care and applicable legal obligations. Institution agrees to obtain from each Study subject, prior to that individual’s participation in the Study, a signed informed consent, approved in writing by Sponsor or Covance and by any applicable ethics committee, and which shall include the necessary content to allow for the Processing of the Study subject’s Personal Data for the purposes described in the Study protocol and the Agreement. 33. Osobní údaje subjektů hodnocení. Zadavatel bude nezávislým Správcem,,co se týká Zpracovávání Osobních údajů obsažených v údajích Studie, které předává Poskytovatel Zadavateli nebo Covance. Poskytovatel bude nadále nezávislým Správcem Osobních údajů Zpracovávaných Poskytovatelem s ohledem na léčbu subjektů hodnocení podle standardů lékařské péče a příslušných právních povinností. Poskytovatel souhlasí s tím, že před individuální účastí ve Studii získá od každého subjektu hodnocení podepsaný informovaný souhlas, písemně schválený Zadavatelem nebo Covance a příslušnou etickou komisí, který bude zahrnovat nezbytný obsah dovolující Zpracovávání Osobních údajů subjektu hodnocení pro účely popsané v protokolu Studie a Smlouvě.
Sample 1See All (6)
AutoNDA by SimpleDocs
Personal Data of Study Subjects. Pfizer will be an independent Controller with respect to its Processing of Personal Data contained in the Study Data and Biological Samples that are reported by Institution or Principal Investigator to Pfizer or otherwise created by Pfizer. Institution or Principal Investigator is the Controller of Personal Data Processed with respect to the medical treatment of the Study Subject.
Sample 1Sample 2
Personal Data of Study Subjects. Pfizer will be an independent Controller with respect to its Processing of Personal Data contained in the Study Data and Biological Samples that are reported by Institution or Principal Investigator, within their Processor capacity, to Pfizer or otherwise created by Pfizer. Institution or Principal Investigator is the Controller of Personal Data Processed by Institution with respect to the medical treatment of the Study Subject and in regards to their medical documentation/patient charts. 2. Osobní údaje subjektů Studie. Společnost Pfizer bude nezávislým Správcem, co se týká Zpracování Osobních údajů obsažených v údajích Studie a Biologických vzorcích, které předává Instituce nebo Hlavní zkoušející společnosti Pfizer, z pozice Zpracovatele, nebo jsou jinak vytvořené společností Pfizer. Instituce nebo Hlavní zkoušející budou Správcem Osobních údajů Zpracovávaných Institucí s ohledem na lékařskou péči subjektů Studie a jejich zdravotnickou dokumentaci.
Sample 1
Personal Data of Study Subjects. Parties acknowledge that Pfizer shall act as an independent Controller with respect to its Processing of coded Personal Data of Study Subjects obtained in accordance with Informed consent form, and with respect to Personal Data of Investigator and Institution's employees obtained in accordance with Agreement that is reported by Institution to Pfizer or CRO. Institution shall act as an independent Controller of any medical records obtained by Investigator from Study Subjects and any other Personal Data gathered or generated by Investigator in the course of the Study for the purposes of conducting his independent medical judgment in accordance with the Protocol and with respect to the treatment of the Study subject pursuant to medical standard of care and applicable legal obligations. The Parties and Pfizer acknowledge that the Investigator shall obtain from each Study subject, prior to that individual’s participation in the Study, a signed informed consent, approved in writing by Pfizer or CRO and by any applicable ethics committee, and which shall include the necessary content to allow for the Processing of the Study subject’s Personal Data for the purposes described in the Study protocol and the Agreement. 2. Osobní údaje subjektů hodnocení. Strany berou na vědomí, že Pfizer jedná jako Správce údajů ve vztahu ke kódovaným Osobním údajům subjektů Studie získaným v souladu s Formulářem informovaného souhlasu a Osobním údajům Zkoušejícího a zaměstnanců Instituce získaným dle Smlouvy. Instituce jedná jako Správce údajů ve vztahu k jakýmkoli zdravotním záznamům, které Zkoušející získal od subjektů Studie, a jakýmkoli dalším osobním údajům, které Zkoušející shromáždil nebo vygeneroval v průběhu Studie pro účely provádění jeho nezávislého lékařského úsudku v souladu s Protokolem a s ohledem na léčbu subjektů hodnocení podle standardů lékařské péče a příslušných právních povinností. Smluvní strany a Pfizer berou na vědomí, že zkoušející před individuální účastí ve Studii získá od každého subjektu hodnocení podepsaný informovaný souhlas, písemně schválený společností Pfizer nebo CRO a příslušnou etickou komisí, který bude zahrnovat nezbytný obsah dovolující Zpracovávání Osobních údajů subjektu hodnocení pro účely popsané v protokolu Studie a Smlouvě.
Sample 1
Personal Data of Study Subjects. 6.2.1 Sponsor, as Controller of the Personal Data of Study Subjects processed for the purpose of the Study (“Study-related Personal Data of Study Subjects”), delegated processing of Study- related Personal Data of Study subjects, including, without limitation, Study-related data on medical condition of Study Subjects, to Institution. The scope of such processing and of the data processed is defined by the case report forms (CRFs) used in this Study and by the Protocol.
Sample 1
Personal Data of Study Subjects. XXX will be an independent Controller with respect to its Processing of Personal Data contained in the Study Data and Biological Samples that are reported by Institution or Principal Investigator to XXX or otherwise created by XXX. Institution or Principal Investigator is the Controller of Personal Data Processed by Institution with respect to the medical treatment of the StudySubject.
Sample 1

Related to Personal Data of Study Subjects

  • Personal Data Registry Operator shall (i) notify each ICANN-­‐accredited registrar that is a party to the registry-­‐registrar agreement for the TLD of the purposes for which data about any identified or identifiable natural person (“Personal Data”) submitted to Registry Operator by such registrar is collected and used under this Agreement or otherwise and the intended recipients (or categories of recipients) of such Personal Data, and (ii) require such registrar to obtain the consent of each registrant in the TLD for such collection and use of Personal Data. Registry Operator shall take reasonable steps to protect Personal Data collected from such registrar from loss, misuse, unauthorized disclosure, alteration or destruction. Registry Operator shall not use or authorize the use of Personal Data in a way that is incompatible with the notice provided to registrars.

  • Processing of Personal Data (a) SORACOM collects and processes personal data about the Subscriber, including name, e-mail, IP-address as well as data on data uses and billing data in order to provide SORACOM’s service and other purposes such as billing.

  • Handling Sensitive Personal Information and Breach Notification A. As part of its contract with HHSC Contractor may receive or create sensitive personal information, as section 521.002 of the Business and Commerce Code defines that phrase. Contractor must use appropriate safeguards to protect this sensitive personal information. These safeguards must include maintaining the sensitive personal information in a form that is unusable, unreadable, or indecipherable to unauthorized persons. Contractor may consult the “Guidance to Render Unsecured Protected Health Information Unusable, Unreadable, or Indecipherable to Unauthorized Individuals” issued by the U.S. Department of Health and Human Services to determine ways to meet this standard.

  • Transfer of Personal Information Supplier warrants to DXC that Personal Information provided to Supplier or obtained by Supplier under this Agreement on behalf of DXC (including any SOW) shall not be transferred across national boundaries unless authorized by law or specified within this Agreement or the applicable SOW as authorized for transfer across national boundaries. Supplier agrees that any such transfer will only be made in compliance with applicable Data Privacy Laws. If there is a conflict between this Section ‘Data Protection and Privacy’ and the other provisions of this Agreement, the requirements of this Section shall take precedence.

Time is Money Join Law Insider Premium to draft better contracts faster.